Case number 1:17-cv-00005
Sanofi-Aventis U.S. LLC et al v. Mylan Pharmaceuticals, Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jan 14, 2017 | 2 | Exhibit 2- Article, "The Father of Embryonic Stem Cell Science Issues Words (3) |
| Jan 14, 2017 | 26 | Report on Filing Patent/Trademark Action (2) |
| Jan 14, 2017 | 25 | Summons (2) |
| Jan 14, 2017 | 24 | Exhibit 24- Statement of Reasons for Patentability and/or Confirmation and Ex Pa (8) |
| Jan 14, 2017 | 23 | Exhibit 23- Lonza Cells on Demand Custom Services Brochure (5) |
| Jan 14, 2017 | 22 | Exhibit 22- November 29, 2016 Letter (5) |
| Jan 14, 2017 | 21 | Exhibit 21- November 4, 2015 Letter (2) |
| Jan 14, 2017 | 20 | Exhibit 20- Lonza's L7 hiPSC Reprogramming Instructions (8) |
| Jan 14, 2017 | 19 | Exhibit 19- Lonza L7 hiPSC Reprogramming Bundles (4) |
| Jan 14, 2017 | 9 | Exhibit 9- U.S. Patent No. 9,447,382 (43) |
| Jan 14, 2017 | 10 | Exhibit 10- Assignment of '038 Patent (5) |
| Jan 14, 2017 | 11 | Exhibit 11- Assignment of '620 Patent (6) |
| Jan 14, 2017 | 12 | Exhibit 12- Assignment of '140 Patent (5) |
| Jan 14, 2017 | 13 | Exhibit 13- Assignment of '574 and '382 Patents (4) |
| Jan 14, 2017 | 14 | Exhibit 14- Assignment of '648 Patent (7) |
| Jan 14, 2017 | 15 | Exhibit 15- Assignment of '470 Patent (7) |
| Jan 14, 2017 | 16 | Exhibit 16- Complaint in 1:16-cv-1304, District of Delaware (25) |
| Jan 14, 2017 | 17 | Exhibit 17- Baghbaderani Article (14) |
| Jan 14, 2017 | 18 | Exhibit 18- Supplemental Experimental Procedures (23) |
| Jan 14, 2017 | 19 | Exhibit 19- Lonza L7 hiPSC Reprogramming Bundles (4) |
| Jan 14, 2017 | 20 | Exhibit 20- Lonza's L7 hiPSC Reprogramming Instructions (8) |
| Jan 14, 2017 | 21 | Exhibit 21- November 4, 2015 Letter (2) |
| Jan 14, 2017 | 22 | Exhibit 22- November 29, 2016 Letter (5) |
| Jan 14, 2017 | 23 | Exhibit 23- Lonza Cells on Demand Custom Services Brochure (5) |
| Jan 14, 2017 | 1 | Main Document (35) |
| Jan 14, 2017 | 24 | Exhibit 24- Statement of Reasons for Patentability and/or Confirmation and Ex Pa (8) |
| Jan 14, 2017 | 1 | Exhibit 1- Article, "America's Best" (2) |
| Jan 14, 2017 | 25 | Summons (2) |
| Jan 14, 2017 | 27 | JS-44 Civil Cover Sheet (2) |
| Jan 14, 2017 | 26 | Report on Filing Patent/Trademark Action (2) |
| Jan 14, 2017 | 3 | Exhibit 3- U.S. Patent No. 8,183,038 (39) |
| Jan 14, 2017 | 27 | JS-44 Civil Cover Sheet (2) |
| Jan 14, 2017 | 4 | Exhibit 4- U.S. Patent No. 8,268,620 (30) |
| Jan 14, 2017 | 5 | Exhibit 5- U.S. Patent No. 8,546,140 (32) |
| Jan 14, 2017 | 6 | Exhibit 6- U.S. Patent No. 8,691,574 (42) |
| Jan 14, 2017 | 7 | Exhibit 7- U.S. Patent No. 8,741,648 (56) |
| Jan 14, 2017 | 8 | Exhibit 8- U.S. Patent No. 8,765,470 (54) |
| Jan 14, 2017 | 9 | Exhibit 9- U.S. Patent No. 9,447,382 (43) |
| Jan 14, 2017 | 10 | Exhibit 10- Assignment of '038 Patent (5) |
| Jan 14, 2017 | 11 | Exhibit 11- Assignment of '620 Patent (6) |
| Jan 14, 2017 | 12 | Exhibit 12- Assignment of '140 Patent (5) |
| Jan 14, 2017 | 13 | Exhibit 13- Assignment of '574 and '382 Patents (4) |
| Jan 14, 2017 | 14 | Exhibit 14- Assignment of '648 Patent (7) |
| Jan 14, 2017 | 15 | Exhibit 15- Assignment of '470 Patent (7) |
| Jan 14, 2017 | 16 | Exhibit 16- Complaint in 1:16-cv-1304, District of Delaware (25) |
| Jan 14, 2017 | 17 | Exhibit 17- Baghbaderani Article (14) |
| Jan 14, 2017 | 18 | Exhibit 18- Supplemental Experimental Procedures (23) |
| Jan 14, 2017 | 8 | Exhibit 8- U.S. Patent No. 8,765,470 (54) |
| Jan 14, 2017 | 7 | Exhibit 7- U.S. Patent No. 8,741,648 (56) |
| Jan 14, 2017 | 6 | Exhibit 6- U.S. Patent No. 8,691,574 (42) |
| Jan 14, 2017 | 5 | Exhibit 5- U.S. Patent No. 8,546,140 (32) |
| Jan 14, 2017 | 4 | Exhibit 4- U.S. Patent No. 8,268,620 (30) |
| Jan 14, 2017 | 3 | Exhibit 3- U.S. Patent No. 8,183,038 (39) |
| Jan 14, 2017 | 2 | Exhibit 2- Article, "The Father of Embryonic Stem Cell Science Issues Words (3) |
| Jan 14, 2017 | 1 | Exhibit 1- Article, "America's Best" (2) |
| Jan 14, 2017 | 1 | Main Document (35) |
